A new study in Science challenges long-held theories of why a common virus—cytomegalovirus, or CMV—can reactivate and become a life-threatening infection in people with a compromised immune system, including blood cancer ...
Jan 17, 2019
0
124
Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers at the University of ...
Jan 15, 2019
0
9
Bone marrow transplants, which involve transplanting healthy blood stem cells, offer the best treatment for many types of cancers, blood disorders and immune diseases. Even though 22,000 of these procedures are performed ...
Jan 9, 2019
0
6
People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England.
Dec 21, 2018
0
3
When Patrick Mannion heard about the Michigan woman denied a heart transplant because she couldn't afford the anti-rejection drugs, he knew what she was up against.
Dec 10, 2018
0
0
The human intestine may provide up to 10 percent of blood cells in circulation from its own reservoir of blood-forming stem cells, a surprising new study from researchers at Columbia University Vagelos College of Physicians ...
Nov 29, 2018
0
508
Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.
Jul 24, 2018
0
5
A type of mouse widely used to assess how the human immune system responds to transplanted stem cells does not reflect what is likely to occur in patients, according to a study by researchers at the Stanford University School ...
Aug 22, 2017
0
124
Researchers at the University of Pittsburgh School of Medicine and the University of Toronto have uncovered the first molecular steps that lead to immune system activation and eventual rejection of a transplanted organ. The ...
Jun 23, 2017
1
309
Orlando- In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital (BWH) has shown that a novel ...
Feb 24, 2017
0
0
